New drug trial targets painful Crohn's strictures
NCT ID NCT06997965
Summary
This study is testing whether the medication mirikizumab can reduce inflammation and improve symptoms in people with Crohn's disease who have developed painful, narrowed sections of intestine called strictures. About 60 adults in the US and Canada will receive the drug for 24 weeks while doctors monitor changes in their scans, symptoms, and quality of life. The main goal is to see if the treatment can shrink these strictures and make it easier for food to pass through.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.